297 related articles for article (PubMed ID: 29155983)
1. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy.
Li J; Liu WD; Yang ZL; Yuan F; Xu L; Li RG; Yang YQ
Gene; 2014 Sep; 548(2):174-81. PubMed ID: 25017055
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy.
Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE
Cardiovasc Pathol; 2007; 16(6):329-35. PubMed ID: 18005871
[TBL] [Abstract][Full Text] [Related]
4. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
[TBL] [Abstract][Full Text] [Related]
5. The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role on Clinical Dilated Cardiomyopathy.
Jiang DS; Yi X; Li R; Su YS; Wang J; Chen ML; Liu LG; Hu M; Cheng C; Zheng P; Zhu XH; Wei X
Mol Med; 2017 Oct; 23():196-203. PubMed ID: 28805231
[TBL] [Abstract][Full Text] [Related]
6. GATA4 loss-of-function mutation underlies familial dilated cardiomyopathy.
Li RG; Li L; Qiu XB; Yuan F; Xu L; Li X; Xu YJ; Jiang WF; Jiang JQ; Liu X; Fang WY; Zhang M; Peng LY; Qu XK; Yang YQ
Biochem Biophys Res Commun; 2013 Oct; 439(4):591-6. PubMed ID: 24041700
[TBL] [Abstract][Full Text] [Related]
7. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy.
Han M; Yang Z; Sayed D; He M; Gao S; Lin L; Yoon S; Abdellatif M
Cardiovasc Res; 2012 Mar; 93(4):645-54. PubMed ID: 22219180
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
9. Cardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and Myocd.
Zhou L; Liu Y; Lu L; Lu X; Dixon RA
PLoS One; 2012; 7(10):e48028. PubMed ID: 23144723
[TBL] [Abstract][Full Text] [Related]
10. Increased Cardiac Arrhythmogenesis Associated With Gap Junction Remodeling With Upregulation of RNA-Binding Protein FXR1.
Chu M; Novak SM; Cover C; Wang AA; Chinyere IR; Juneman EB; Zarnescu DC; Wong PK; Gregorio CC
Circulation; 2018 Feb; 137(6):605-618. PubMed ID: 29101288
[TBL] [Abstract][Full Text] [Related]
11. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.
Koentges C; Pepin ME; Müsse C; Pfeil K; Alvarez SVV; Hoppe N; Hoffmann MM; Odening KE; Sossalla S; Zirlik A; Hein L; Bode C; Wende AR; Bugger H
Basic Res Cardiol; 2018 Jan; 113(1):8. PubMed ID: 29288409
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.
Li H; Xu JD; Fang XH; Zhu JN; Yang J; Pan R; Yuan SJ; Zeng N; Yang ZZ; Yang H; Wang XP; Duan JZ; Wang S; Luo JF; Wu SL; Shan ZX
Cardiovasc Res; 2020 Jun; 116(7):1323-1334. PubMed ID: 31397837
[TBL] [Abstract][Full Text] [Related]
14. Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
Huang Y; Lu H; Ren X; Li F; Bu W; Liu W; Dailey WP; Saeki H; Gabrielson K; Abraham R; Eckenhoff R; Gao WD
Cardiovasc Res; 2020 May; 116(6):1175-1185. PubMed ID: 31424496
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.
McMullen JR; Amirahmadi F; Woodcock EA; Schinke-Braun M; Bouwman RD; Hewitt KA; Mollica JP; Zhang L; Zhang Y; Shioi T; Buerger A; Izumo S; Jay PY; Jennings GL
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):612-7. PubMed ID: 17202264
[TBL] [Abstract][Full Text] [Related]
16. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.
Bisping E; Ikeda S; Kong SW; Tarnavski O; Bodyak N; McMullen JR; Rajagopal S; Son JK; Ma Q; Springer Z; Kang PM; Izumo S; Pu WT
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14471-6. PubMed ID: 16983087
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4.
Kwon DH; Eom GH; Kee HJ; Nam YS; Cho YK; Kim DK; Koo JY; Kim HS; Nam KI; Kim KK; Lee IK; Park SB; Choi HS; Kook H
J Mol Cell Cardiol; 2013 Dec; 65():88-97. PubMed ID: 24083978
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Hypoxia-Inducible Factor 1α-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
Mirtschink P; Bischof C; Pham MD; Sharma R; Khadayate S; Rossi G; Fankhauser N; Traub S; Sossalla S; Hagag E; Berthonneche C; Sarre A; Stehr SN; Grote P; Pedrazzini T; Dimmeler S; Krek W; Krishnan J
Circulation; 2019 Jun; 139(24):2778-2792. PubMed ID: 30922078
[TBL] [Abstract][Full Text] [Related]
19. FOG-2 mediated recruitment of the NuRD complex regulates cardiomyocyte proliferation during heart development.
Garnatz AS; Gao Z; Broman M; Martens S; Earley JU; Svensson EC
Dev Biol; 2014 Nov; 395(1):50-61. PubMed ID: 25196150
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor GATA-6 regulates pathological cardiac hypertrophy.
van Berlo JH; Elrod JW; van den Hoogenhof MM; York AJ; Aronow BJ; Duncan SA; Molkentin JD
Circ Res; 2010 Oct; 107(8):1032-40. PubMed ID: 20705924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
